BIO Medical Applications Of Alabama Inc in Enterprise, Alabama - Dialysis Center

BIO Medical Applications Of Alabama Inc is a medicare approved dialysis facility center in Enterprise, Alabama and it has 10 dialysis stations. It is located in Coffee county at 6004 Boll Weevil Circle, Enterprise, AL, 36330. You can reach out to the office of BIO Medical Applications Of Alabama Inc at (334) 393-0024. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Alabama Inc has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 012689 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBIO Medical Applications Of Alabama Inc
Location6004 Boll Weevil Circle, Enterprise, Alabama
No. of Dialysis Stations 10
Medicare ID012689
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


6004 Boll Weevil Circle, Enterprise, Alabama, 36330
(334) 393-0024
Not Available

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with BIO Medical Applications Of Alabama Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1528433943
Organization NameFresenius Medical Care Enterprise
Doing Business AsBio-medical Applications Of Alabama, Inc.
Address6004 Boll Weevil Cir Enterprise, Alabama, 36330
Phone Number(334) 393-0024

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data1

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center4
    Adult patient months included in Kt/V greater than or equal to 1.216
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Alabama Inc with elevated calcium levels.

Patients with hypercalcemia4
Hypercalcemia patient months16
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor4
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 5
Patient months included in arterial venous fistula and catheter summaries 17
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer